Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
about
ARID2: a new tumor suppressor gene in hepatocellular carcinomaOverlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functionsSialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responsesCD8(+) T cell activation by murine erythroblasts infected with malaria parasites.Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.A20 modulates lipid metabolism and energy production to promote liver regenerationSustained signaling by canonical helper T cell cytokines throughout the reactive lymph node.A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human gammadelta T lymphocytesInterferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells.PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.Soluble mediators regulating immunity in early lifeMechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblastsImmune sculpting of norepinephrine on MHC-I, B7-1, IDO and B7-H1 expression and regulation of proliferation and invasion in pancreatic carcinoma cellsIRF1 and NF-kB restore MHC class I-restricted tumor antigen processing and presentation to cytotoxic T cells in aggressive neuroblastomaMHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroNovel roles for immune molecules in neural development: implications for neurodevelopmental disorders.Regulation of hepatocyte fate by interferon-γ.Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.Protective immunity against acute toxoplasmosis in BALB/c mice induced by a DNA vaccine encoding Toxoplasma gondii elongation factor 1-alpha.HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisitionApoptotic cell-treated dendritic cells induce immune tolerance by specifically inhibiting development of CD4⁺ effector memory T cells.Aging Converts Innate B1a Cells into Potent CD8+ T Cell InducersIntravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity CancersComprehensive genomic profiling in diabetic nephropathy reveals the predominance of proinflammatory pathways.IFNγ is Required for Optimal Antibody-Mediated Immunity against Genital Chlamydia Infection.Comparative analysis of gingival tissue antigen presentation pathways in ageing and periodontitis.CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites.The clinical implications of antitumor immunity in head and neck cancer.Census of cytosolic aminopeptidase activity reveals two novel cytosolic aminopeptidases.Generating hESCs with reduced immunogenicity by disrupting TAP1 or TAPBP.Comparative analysis of immune effects in mice model: Clonorchis sinensis cysteine protease generated from recombinant Escherichia coli and Bacillus subtilis spores.Vascular-targeted TNFα and IFNγ inhibits orthotopic colorectal tumor growthHIV-TB coinfection impairs CD8(+) T-cell differentiation and function while dehydroepiandrosterone improves cytotoxic antitubercular immune responses.Innate and adaptive immune responses to in utero infection with bovine viral diarrhea virus.Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma.Immunoproteasomes edit tumors, which then escapes immune recognitionCorrelation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I.
P2860
Q24607045-80AD1761-F2A7-4086-95D8-F9F5B7D0F14BQ27014714-65AA2E10-2A33-41AE-855F-D239AF5E44D2Q30367426-75B2C6BE-896F-46F4-85AE-FF512FF4E3D2Q30538105-E45FCD8B-EC78-4513-90BE-136165384BB5Q33610214-3FD12F52-689D-45FE-9721-BEE89BBCC89BQ33719537-1871CFDB-373A-4D0B-8FF3-C1105A0BC6F2Q33855522-53F55CFC-C28A-4ABB-9BC8-CD8B245EED57Q33957034-ACF5A764-1B5D-4148-9CBD-BB6E5575B631Q34002174-1CA87C76-4622-42DA-8166-79AB9C9AF584Q34015431-EC79BBDC-2E69-41F1-B315-720C345E8DB1Q34076409-10B36A17-17B9-41DA-B4A3-B38E1399D64AQ34238426-BD1163C4-2B22-41DB-A0E4-AD7D9222856BQ34291222-ED410EEC-3D43-4B39-8F49-A892D3AB6258Q34429197-F986E8B1-7E22-441D-B4C9-B5DC133F4278Q34447613-9FCD7B12-FA4D-407B-9BF8-04A26C456905Q34615021-35369043-4E39-4BA6-867F-29C019293476Q34689823-B99C5375-A8DF-4440-B4FA-08085FB3A99CQ34748063-E2E49602-07D4-40B4-941B-3555986B0CF2Q35693349-56F2BB9D-CEE3-4D03-B23C-9C7ED10A21DBQ35819992-2DAFCB02-ED5E-430C-B728-6FC377D19898Q36184954-445AEE3E-2907-4A52-A314-504A0D9514A8Q36405155-60892478-1CEE-4E0C-A200-BA97DF27418BQ36767874-A3CE19B4-3BB4-42DE-AA0A-BF85972BA6B5Q37026218-7B10D221-265E-4C91-AA3F-BA9B5C0D7557Q37045403-B5791A2B-F196-43E1-A7DE-51F042005793Q37059878-717CC456-12BB-47EB-BDA4-C22B581709FEQ37093818-4C832431-6EB0-4D1D-91F9-9880501E147BQ37345928-D709108C-B288-4126-A2FA-16A24201454EQ37632781-773D07A5-36A2-4BD5-8745-37D65473AC4BQ37698282-912E17FF-9832-41CE-8D77-8BEA211057E3Q37970005-E9FBA593-B93B-4D44-835F-55010337C25DQ38043403-6B57F597-228F-4890-8E75-19FC42875778Q38882610-FA3C0CFC-2CD3-409E-8914-686DF1D6ABD9Q39605791-C6985CA6-1CBD-4787-A770-675226A9E3C6Q39656460-EE20D936-8215-4E2D-903A-486CAFCD723AQ40865499-07C41862-220B-4A23-A193-F8B4ED711765Q41179298-F05A1A0E-811B-4396-869A-136DE03D33A9Q41316816-12BC4537-CF2F-4F61-BF42-97B9B977BB17Q41497500-4C7E3230-84F7-43E8-AE0F-50E4C5D79305Q41862292-DF9FE04F-6BCA-498E-8AB6-9619B9751418
P2860
Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@en
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@nl
type
label
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@en
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@nl
prefLabel
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@en
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@nl
P2860
P1476
Molecular mechanisms of IFN-ga ...... n processing and presentation.
@en
P2093
P2860
P304
P356
10.1080/08830180902978120
P577
2009-01-01T00:00:00Z